Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Raimondi

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Giornale Di Clinica Medica|October 1, 1979
[Some simple indices for evaluation of the nutritional state of chronic uremic patients treated with periodic hemodialysis]G F Guarnieri, F Ranieri, D Giuntini, et al.
Current Medicinal Chemistry|January 5, 2012
mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphomaA Guarini, C Minoia, M Giannoccaro, et al.
The American Journal of Clinical Nutrition|July 1, 1980
Simple methods for nutritional assessment in hemodialyzed patientsG Guarnieri, L Faccini, T Lipartiti, et al.
The Journal of Experimental Medicine|May 5, 1997
The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residuesB Galocha, A Hill, B C Barnett, et al.
Molecular Cell|October 13, 1999
Identification of the major intestinal fatty acid transport proteinA Stahl, D J Hirsch, R E Gimeno, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025R Fazio, M Ambrosini, A Raimondi, et al.
ESMO Open|October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONOD Rossini, A Boccaccino, A Sbrana, et al.
ESMO Open|August 20, 2021
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino studyA Raimondi, G Fucà, A G Leone, et al.
Medicina|November 22, 2005
[Argentine consensus of non-invasive ventilation]Ana R Diez, Horacio Abbona, Gerardo Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationF Morano, S Corallo, M Niger, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Giornale Di Clinica Medica|October 1, 1979
[Some simple indices for evaluation of the nutritional state of chronic uremic patients treated with periodic hemodialysis]G F Guarnieri, F Ranieri, D Giuntini, et al.
Current Medicinal Chemistry|January 5, 2012
mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphomaA Guarini, C Minoia, M Giannoccaro, et al.
The American Journal of Clinical Nutrition|July 1, 1980
Simple methods for nutritional assessment in hemodialyzed patientsG Guarnieri, L Faccini, T Lipartiti, et al.
The Journal of Experimental Medicine|May 5, 1997
The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residuesB Galocha, A Hill, B C Barnett, et al.
Molecular Cell|October 13, 1999
Identification of the major intestinal fatty acid transport proteinA Stahl, D J Hirsch, R E Gimeno, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025R Fazio, M Ambrosini, A Raimondi, et al.
ESMO Open|October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONOD Rossini, A Boccaccino, A Sbrana, et al.
ESMO Open|August 20, 2021
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino studyA Raimondi, G Fucà, A G Leone, et al.
Medicina|November 22, 2005
[Argentine consensus of non-invasive ventilation]Ana R Diez, Horacio Abbona, Gerardo Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationF Morano, S Corallo, M Niger, et al.
Pageof 10